Chinese Influenza Weekly Report

Similar documents
Chinese Influenza Weekly Report

Chinese Influenza Weekly Report

Chinese Influenza Weekly Report

Chinese Influenza Weekly Report

Chinese Influenza Weekly Report

Chinese Influenza Weekly Report

Influenza Surveillance Summary: Denton County Hospitals and Providers 17.51% 15.95% 10.94% 7.41% 9.01% 8.08%

RESPIRATORY VIRUS SURVEILLANCE REPORT

Surveillance Overview

MASSACHUSETTS DEPARTMENT OF PUBLIC HEALTH WEEKLY INFLUENZA UPDATE January 26, 2018

Summary. Week 11/2017 (13 19 March 2017) Season overview

Influenza Global Epidemiologic Update

Influenza Update N 157

Influenza Situation Update

Seasonal Influenza Report

Seasonal Influenza Report

Bi-weekly Influenza Situation Update

Questions and Answers

Influenza Situation Update

Seasonal Influenza Report

Community and Hospital Surveillance

Influenza Situation Update

Influenza Update N 159

Influenza surveillance summary

Influenza Surveillance in Ireland Weekly Report Influenza Week (11 th 17 th December 2017)

Risk assessment of seasonal influenza - Update, EU/EEA, January 2017

Summary. Week 15/2018 (9 15 April 2018) season overview

Centers for Disease Control and Prevention U.S. INFLUENZA SEASON SUMMARY*

Summary. Week 4/2018 (22 28 January 2018) season overview


Influenza Surveillance in Ireland Weekly Report Influenza Week (22 nd 28 th January 2018)

Influenza Situation Update

Influenza Activity Update

Summary. Week 13/2018 (26 31 March 2018) season overview

NC IMMUNIZATION COALITION FLU THEN AND NOW NC DHHS COMMUNICABLE DISEASE BRANCH ANITA VALIANI, MPH AUGUST 1, 2018

GIHSN-China s experience & Results of season Beijing, China

Main conclusions and options for response

Table 1: Summary of Texas Influenza (Flu) and Influenza-like Illness (ILI) Activity for the Current Week Texas Surveillance Component

Flu Watch. MMWR Week 4: January 21 to January 27, and Deaths. Virologic Surveillance. Influenza-Like Illness Surveillance

REPORT. Early risk assessment: What to expect of the 2017/18 influenza season in Norway

Week 11: March 11 to March 17, 2018

Week 15: April 8 to April 14, 2018

British Columbia Influenza Surveillance Bulletin Influenza Season , Number 23, Weeks August 13 to September 23, 2017

Seasonal Influenza Report

Seasonal Influenza Report

RAPID RISK ASSESSMENT. Risk assessment of seasonal influenza, EU/EEA, Conclusions and options for response. Update, 25 January 2017

Influenza Situation Update

Global Influenza Virus Surveillance and WHO Influenza Vaccine Virus Recommendations for the Northern Hemisphere Influenza Season

Influenza Situation Update


Texas Influenza Summary Report, Season (September 28, 2008 April 11, 2009)

Influenza Prevention Update

Influenza Surveillance in Ireland Weekly Report Influenza Week (12 th 18 th March 2018)

Influenza Weekly Surveillance Bulletin

Bi-weekly Influenza Situation Update

Alberta Health. Seasonal Influenza in Alberta. 2016/2017 Season. Analytics and Performance Reporting Branch

Influenza Weekly Surveillance Bulletin

Weekly Influenza Report

Influenza Surveillance in Ireland Weekly Report Influenza Weeks 13 & (26 th March 8 th April 2018)

British Columbia Influenza Surveillance Bulletin

Flu Watch. MMWR Week 3: January 14 to January 20, and Deaths. Virologic Surveillance. Influenza-Like Illness Surveillance

December 3 to 9, 2017 (Week 49)

Influenza Update N 176

Influenza Weekly Surveillance Bulletin

Bi-weekly Influenza Situation Update

Influenza Weekly Surveillance Bulletin

Alberta Health. Seasonal Influenza in Alberta Season. Analytics and Performance Reporting Branch

WEEKLY INFLUENZA REPORT

Summary: Increasing Activity

Incorporating virologic data into seasonal and pandemic influenza vaccines

What to expect of the 2018/19 influenza season in Norway

Centers for Disease Control and Prevention U.S. INFLUENZA SEASON SUMMARY*

Alberta Health. Seasonal Influenza in Alberta. 2012/2013 Season. Surveillance and Assessment Branch. November Government of Alberta 1

Weekly Influenza Report

Week 11 (Mar.13 19, 2016)

WHO NIC at Research Institute of Influenza and D.I. Ivanovsky Institute of Virology INTEGRATED DATA OF INFLUENZA MORBIDITY AND DIAGNOSIS

Influenza and other Respiratory Viruses Update

Annual Epidemiological Report DRAFT

Influenza Weekly Surveillance Bulletin

WHO NIC at Research Institute of Influenza and D.I. Ivanovsky Institute of Virology INTEGRATED DATA OF INFLUENZA MORBIDITY AND DIAGNOSIS

Manitoba Health, Healthy Living and Seniors (MHHLS) Week 9 (Feb.28 Mar.5, 2016) == Severe outcomes associated with. == Cases and cumulative incidence

November 5 to 11, 2017 (Week 45)

WEEKLY INFLUENZA REPORT

Update on Influenza Vaccines, the Influenza Season, and the Impact of Vaccination on Influenza Disease Burden

Influenza Weekly Surveillance Bulletin

Summary: Low activity

MASSACHUSETTS DEPARTMENT OF PUBLIC HEALTH WEEKLY INFLUENZA UPDATE January 4, 2019

Influenza Weekly Surveillance Bulletin

Influenza Activity in Indiana

Summary: Low activity

MEETING THE STANDARDS: FDA MANDATORY RAPID INFLUENZA DETECTION TEST (RIDTs) RECLASSIFICATION

Influenza Surveillance in Ireland Weekly Report Influenza Week (12 th 18 th November 2018)

WEEKLY INFLUENZA REPORT

Summary: Sustained Influenza B Activity

Influenza Surveillance in Ireland Weekly Report Influenza Week (1 st 7 th October 2018)

Weekly Influenza Report

Week 43 (Oct , 2016)

INFLUENZA WEEKLY UPDATE 2014/25: June 2014

Influenza Weekly Surveillance Bulletin

Summary. Primary care data. Week 49/2014. Season

Transcription:

Chinese Influenza Weekly Report (All data are preliminary and may change as more reports are received) Summary During week 10, influenza activity was still a little high in southern and northern China with A(H3N2) and A(H1N1)pdm09 virus epidemic, A(H1N1)pdm09 viruses had exceeded A(H3N2) in northern China. Among influenza viruses antigenically characterized by CNIC since September, 2016, 164(100%) influenza A(H1N1)pdm09 viruses were characterized as A/California/7/2009-like; 151(100%) influenza A(H1N1)pdm09 viruses were characterized as A/Michigan/45/2015-like; 221(49.6%) influenza A(H3N2) viruses were characterized as A/Hong Kong/4801/2014 (H3N2)(EGG)-like,435(97.5%) influenza A(H3N2) viruses were characterized as A/Hong Kong/4801/2014 (H3N2)(CELL)-like; 184(99.5%) influenza B/Victoria viruses were characterized as B/Brisbane/60/2008-like; 60(92.3%) influenza B/Yamagata viruses were characterized as B/Phuket/3073/2013-like. Among the influenza viruses tested by CNIC for antiviral resistance analysis since September, 2016, all influenza A(H1N1)pdm09 and all influenza A(H3N2) viruses were resistant to adamantine; All influenza A(H1N1)pdm09 and all influenza H3N2 and B viruses were sensitive to neuraminidase inhibitors. 1

Outbreak Surveillance During week 10(Mar 6 th - Mar 12 th, 2017), there were 21 outbreaks reported nationwide, 2 of them were A(H1N1), 3 of them were A(H3N2), 14 of them were B, 1 of them was A(Unsubtyped), 1 of them was untyped. Surveillance of outpatient or emergency visits for Influenza-like Illness (ILI) During week 10, the percentage of outpatient or emergency visits for ILI (ILI %) at national sentinel hospitals in south China was 3.0%, same as last week (3.0%), higher than the same week of 2015 (2.4%), lower than the same week of 2016 (3.6%). (Figure 1) Figure 1. Percentage of Visits for ILI at Sentinel Hospitals in South China (2012-2017) During week 10, ILI% at national sentinel hospitals in north China was 3.2%, higher than last week and the same week of 2015 (3.0% both 2.6%), lower than the same week of 2016(3.8%). (Figure 2) 2

Figure 2. Percentage of Visits for ILI at Sentinel Hospitals in North China (2012-2017) Virologic Surveillance During week 10, influenza network laboratories tested 7062 specimens, of which 1140(16.1%) were positive for influenza, influenza A and influenza B virus were 1138(86.1%) and 159(13.9%), respectively (Table 1). During week 10, the percentage of specimens that were tested positive for influenza in south China was 12.6%, which was lower than the previous week (13.1%) (Figure 3). During week 10, the percentage of specimens that were tested positive for influenza in north China was 20.3%, which was higher than the previous week (17.9%). (Figure 4). Table 1 Laboratory Detections of ILI Specimens (Week 10, 2017) Week 10 South China North China Total No. of specimens tested 3780 3282 7062 No. of positive specimens (%) 475(12.6%) 665(20.3%) 1140(16.1%) Influenza A 332(69.9%) 649(97.6%) 981(86.1%) A(H3N2) 156(47.0%) 178(27.4%) 334(34.0%) A(H1N1)pdm09 173(52.1%) 470(72.4%) 643(65.5%) 3

A (subtype not determined) 3(0.9%) 1(0.2%) 4(0.4%) Influenza B 143(30.1%) 16(2.4%) 159(13.9%) B (lineage not determined) 5(3.5%) 1(6.3%) 6(3.8%) Victoria 109(76.2%) 3(18.8%) 112(70.4%) Yamagata 29(20.3%) 12(75.0%) 41(25.8%) Figure 3. Influenza Positive Tests Reported by Southern Network Laboratories (Week 14, 2015 Week 10, 2017) Note: Analysis in this part was based on the test results of network laboratories. If it were not consistent with the results of CNIC confirmation, the results of CNIC confirmation were used. 4

Figure 4. Influenza Positive Tests Reported by Northern Network Laboratories (Week 14, 2015 Week 10, 2017) Note: Analysis in this part was based on the result of network laboratories. If it were not consistent with the results of CNIC confirmation, the results of CNIC confirmation were used. Antigenic Characterization Since September 1 st, 2016, all of the 164 A(H1N1)pdm09 viruses tested were characterized as A/California/7/2009-like; all of the 151 A(H1N1)pdm09 viruses tested were characterized as A/Michigan/45/2015-like;221(49.6%) of the 446 A(H3N2) influenza viruses tested were characterized as A/Hong Kong/4801/2014 (H3N2)(EGG)-like, 435(97.5%) of the 446 A(H3N2) influenza viruses tested were characterized as A/Hong Kong/4801/2014 (H3N2)(CELL)-like; 184(99.5%) of the 185 influenza B/Victoria lineage viruses tested were characterized as B/Brisbane/60/2008-like; 60(92.3%) of the 65 influenza B/Yamagata lineage viruses tested were characterized as B/Phuket/3073/2013-like. Antiviral Resistance Since September 1 st, 2016, among the influenza viruses tested by CNIC for antiviral resistance, all influenza A(H1N1)pdm09 and all influenza A(H3N2) viruses were resistant to adamantine ; All influenza A(H1N1)pdm09 and all influenza A(H3N2) and B viruses were sensitive to neuraminidase inhibitors. 5